slotkoers
Korea S.E.
00:00:00 07-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
6.280
KRW
|
+0,16%
|
|
-0,32%
|
-10,29%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
81.039
|
101.386
|
139.365
|
141.509
|
108.181
|
95.597
|
Bedrijfswaarde
1 |
70.022
|
86.228
|
124.018
|
122.360
|
93.600
|
100.542
|
K/w-verhouding
|
9,22
x
|
8,04
x
|
13,8
x
|
9,88
x
|
7,83
x
|
7,68
x
|
Dividendrendement
|
1,55%
|
1,8%
|
1,23%
|
1,72%
|
2,07%
|
2,29%
|
Marktkapitalisatie/omzet
|
1,44
x
|
1,56
x
|
2,26
x
|
1,9
x
|
1,31
x
|
0,98
x
|
Bedrijfswaarde/omzet
|
1,24
x
|
1,32
x
|
2,01
x
|
1,65
x
|
1,13
x
|
1,03
x
|
Bedrijfswaarde/EBITDA
|
5,37
x
|
4,84
x
|
8,62
x
|
6,6
x
|
5,05
x
|
5,9
x
|
Bedrijfswaarde/FCF
|
467
x
|
45,6
x
|
82,5
x
|
127
x
|
-20,9
x
|
-15,7
x
|
FCF Yield
|
0,21%
|
2,19%
|
1,21%
|
0,79%
|
-4,78%
|
-6,38%
|
Price to Book
|
1,8
x
|
1,79
x
|
2,09
x
|
1,79
x
|
1,23
x
|
1
x
|
Aantal aandelen (in duizenden)
|
12.532
|
13.732
|
14.294
|
14.294
|
13.977
|
13.657
|
Referentieprijs
2 |
6.467
|
7.383
|
9.750
|
9.900
|
7.740
|
7.000
|
Datum van publicatie
|
28/02/19
|
28/02/20
|
26/02/21
|
25/02/22
|
28/02/23
|
21/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
56.289
|
65.106
|
61.688
|
74.290
|
82.604
|
97.897
|
EBITDA
1 |
13.051
|
17.821
|
14.384
|
18.529
|
18.551
|
17.035
|
Bedrijfsresultaat (EBIT)
1 |
10.958
|
14.668
|
11.119
|
14.968
|
14.918
|
12.757
|
Operationele Marge
|
19,47%
|
22,53%
|
18,03%
|
20,15%
|
18,06%
|
13,03%
|
Resultaat voor belastingen (EBT)
1 |
11.046
|
14.982
|
10.700
|
15.787
|
15.704
|
12.961
|
Nettowinst (verlies)
1 |
9.472
|
13.240
|
10.172
|
14.323
|
13.900
|
12.486
|
Nettomarge
|
16,83%
|
20,34%
|
16,49%
|
19,28%
|
16,83%
|
12,75%
|
WPA
2 |
701,0
|
917,8
|
709,0
|
1.002
|
988,0
|
911,5
|
Free Cash Flow
1 |
149,9
|
1.890
|
1.503
|
962,4
|
-4.470
|
-6.413
|
FCF-marge
|
0,27%
|
2,9%
|
2,44%
|
1,3%
|
-5,41%
|
-6,55%
|
Kasstroomconversie (ebitda)
|
1,15%
|
10,6%
|
10,45%
|
5,19%
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
1,58%
|
14,27%
|
14,77%
|
6,72%
|
-
|
-
|
Dividend per aandeel
2 |
100,0
|
133,0
|
120,0
|
170,0
|
160,0
|
160,0
|
Datum van publicatie
|
28/02/19
|
28/02/20
|
26/02/21
|
25/02/22
|
28/02/23
|
21/03/24
|
Fiscaal tijdperk: december |
2023 Q3
|
---|
Omzet
|
-
|
EBITDA
|
-
|
Bedrijfsresultaat (EBIT)
|
-
|
Operationele Marge
|
-
|
Resultaat voor belastingen (EBT)
|
-
|
Nettowinst (verlies)
1 |
3,041
|
Nettomarge
|
-
|
WPA
2 |
223,0
|
Dividend per aandeel
|
-
|
Datum van publicatie
|
14/11/23
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
4.945
|
Nettokaspositie
1 |
11.016
|
15.158
|
15.347
|
19.149
|
14.581
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
0,2903
x
|
Free Cash Flow
1 |
150
|
1.890
|
1.503
|
962
|
-4.470
|
-6.413
|
ROE (netto-inkomsten/eigen vermogen)
|
27,3%
|
25,3%
|
16,1%
|
19,7%
|
16,7%
|
13,5%
|
ROA (netto-inkomsten/totale activa)
|
14,2%
|
13,4%
|
8,46%
|
10,1%
|
9,07%
|
6,92%
|
Totale activa
1 |
66.506
|
98.900
|
120.219
|
141.714
|
153.239
|
180.463
|
Nettoactief per aandeel
2 |
3.589
|
4.124
|
4.654
|
5.522
|
6.294
|
6.982
|
Cashflow per aandeel
2 |
815,0
|
1.005
|
1.292
|
1.403
|
362,0
|
379,0
|
Capex
1 |
1.382
|
1.001
|
566
|
5.335
|
9.248
|
2.888
|
Capex/omzet
|
2,46%
|
1,54%
|
0,92%
|
7,18%
|
11,2%
|
2,95%
|
Datum van publicatie
|
28/02/19
|
28/02/20
|
26/02/21
|
25/02/22
|
28/02/23
|
21/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -10,29% | 62,24 mln. | | -11,43% | 13,72 mld. | | -44,31% | 2,55 mld. | | -13,72% | 2,43 mld. | | -21,19% | 1,31 mld. | | -.--% | 1,12 mld. | | +94,36% | 515 mln. | | +23,08% | 453 mln. | | +31,39% | 285 mln. | | -11,03% | 203 mln. |
Medische Beeldvormingssystemen
|